Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell lines

This publication has 14 references indexed in Scilit:

• Activation of deoxycytidine kinase during inhibition of DNA synthesis in human lymphocytes
  Clinical Biochemistry, 1997
• Increased Deoxycytidine Kinase Activity by Etoposide in L1210 Murine Leukemic Cells.
  Biological & Pharmaceutical Bulletin, 1996
• Schedule dependence of sensitivity to 2′,2′-difluorodeoxycytidine (gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours
  Biochemical Pharmacology, 1994
• Transformation of mouse fibroblasts with the oncogenes H-ras ortrk is associated with pronounced changes in drug sensitivity and metabolism
  International Journal of Cancer, 1993
• Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing
  European Journal of Cancer and Clinical Oncology, 1991
• 2'-Deoxy-2'-methylenecytidine and 2'-deoxy-2',2'-difluorocytidine 5'-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductase
  Journal of Medicinal Chemistry, 1991
• Stabilization of the topoisomerase II-DNA cleavage complex by antineoplastic drugs: inhibition of enzyme-mediated DNA religation by 4'-(9-acridinylamino)methanesulfon-m-anisidide
  Biochemistry, 1990
• Synthesis of 2-deoxy-2,2-difluoro-D-ribose and 2-deoxy-2,2'-difluoro-D-ribofuranosyl nucleosides
  The Journal of Organic Chemistry, 1988
• Concentration of nucleotides and deoxynucleotides in peripheral and phytohemagglutinin-stimulated mammalian lymphocytes
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1983
• Combination chemotherapy with 4′Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-β-d-glucopyranoside), VP 16–213 (NSC 141540) in L1210 Leukemia
  Published by Elsevier ,1976